His primary areas of study are Pathology, Cancer, Metastasis, Circulating tumor cell and Bone marrow. His studies in Pathology integrate themes in fields like Breast cancer and Primary tumor. In Cancer, Klaus Pantel works on issues like Disease, which are connected to Personalized medicine and Tumor microenvironment.
His work carried out in the field of Metastasis brings together such families of science as Extracellular matrix, Epithelial cell adhesion molecule, Lung and Monoclonal antibody. The various areas that he examines in his Circulating tumor cell study include Peripheral blood, Cancer research, Colorectal cancer and Oncology. His research integrates issues of Adjuvant therapy, Disseminated Tumor Cell, Antigen and Micrometastasis in his study of Bone marrow.
His main research concerns Internal medicine, Oncology, Pathology, Circulating tumor cell and Cancer. Klaus Pantel combines subjects such as Esophageal cancer, Clinical significance, Proportional hazards model, Biomarker and Prospective cohort study with his study of Oncology. Klaus Pantel interconnects Primary tumor and Metastasis in the investigation of issues within Pathology.
Klaus Pantel has included themes like Liquid biopsy, Colorectal cancer, Clinical trial and Peripheral blood in his Circulating tumor cell study. His research in Cancer intersects with topics in Cancer research, Lung cancer and Minimal residual disease. The concepts of his Breast cancer study are interwoven with issues in Immunohistochemistry and Surgical oncology.
Klaus Pantel mainly investigates Circulating tumor cell, Internal medicine, Cancer research, Oncology and Cancer. His Circulating tumor cell research integrates issues from Clinical trial, Chemotherapy, Liquid biopsy, Breast cancer and Primary tumor. His Cancer research study combines topics in areas such as Bladder cancer, Cystectomy, Metastasis, Prostate cancer and Bone marrow.
His Bone marrow study incorporates themes from Haematopoiesis and Bone metastasis. His Oncology study integrates concerns from other disciplines, such as Prospective cohort study, Metastatic breast cancer, Proportional hazards model and Trastuzumab. The Cancer study combines topics in areas such as Carcinoma, Pathology, Minimal residual disease and microRNA.
Klaus Pantel spends much of his time researching Circulating tumor cell, Cancer research, Internal medicine, Oncology and Cancer. His Circulating tumor cell research is multidisciplinary, incorporating perspectives in Chemotherapy, Lung cancer, Pathology, Liquid biopsy and Hazard ratio. His Pathology research incorporates elements of Cancer stem cell and Primary tumor.
His Cancer research research includes themes of Epithelial–mesenchymal transition, Metastasis, Cell, Clinical significance and Carcinoma. His Oncology research is multidisciplinary, relying on both Survival analysis, Metastatic breast cancer, Proportional hazards model and Clinical trial. The study incorporates disciplines such as Immune system and Bone marrow, Minimal residual disease in addition to Cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach;Dave S. B. Hoon;Klaus Pantel.
Nature Reviews Cancer (2011)
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino;Bruno Costa-Silva;Tang-Long Shen;Goncalo Rodrigues.
Dissecting the metastatic cascade
Klaus Pantel;Ruud H. Brakenhoff.
Nature Reviews Cancer (2004)
In vitro differentiation of endothelial cells from AC133-positive progenitor cells
Ursula M. Gehling;Süleyman Ergün;Udo Schumacher;Christoph Wagener.
A pooled analysis of bone marrow micrometastasis in breast cancer
Stephan Braun;Florian D. Vogl;Bjørn Naume;Wolfgang Janni.
The New England Journal of Medicine (2005)
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
Stephan Braun;Klaus Pantel;Peter Müller;Wolfgang Janni.
The New England Journal of Medicine (2000)
Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System
Sabine Riethdorf;Herbert Fritsche;Volkmar Müller;Thomas Rau.
Clinical Cancer Research (2007)
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Klaus Pantel;Ruud H. Brakenhoff;Burkhard Brandt.
Nature Reviews Cancer (2008)
Challenges in circulating tumour cell research.
Catherine Alix-Panabières;Klaus Pantel.
Nature Reviews Cancer (2014)
Circulating Tumor Cells: Liquid Biopsy of Cancer
Catherine Alix-Panabières;Klaus Pantel.
Clinical Chemistry (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: